Similar Items: Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
- Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
- Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
- Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
- Antiretroviral therapy adherence and effectiveness in a private sector disease management programme in Southern Africa
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- Effect of dihydroartemisin-piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV
Author: Sinxadi, Phumla
- Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
- Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
- Pharmacogenetics of Tenofovir (Alafenamide or Disoproxil Fumarate Prodrug) Renal Toxicity in HIV positive Black Southern Africans